Piramal Pharma Solutions (PPS), a contract development and manufacturing organisation (CDMO) announced investments of USD 55 million across its sites in North America and Asia to expand its API manufacturing capabilities and capacities.

A part of USD 55 million investment will go into new multi-purpose plants, with over 270kL of total capacity, to support the current pipeline of approximately 80 late-stage programs that PPS is currently assisting its partners with at various global Clients.

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/piramal-pharma-announces-expansion-of-api-manufacturing-facilities/articleshow/61022366.cms

About news

We take care of publishing the latest investment news and highlights for Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *